Psych News Alert | antipsychotic (2)

Reviewing the FDA’s Major Psychiatry Approvals in 2024

12/27/24, 12:00 AM

New Schizophrenia Drug Shows Marked Effect on Cognitive Deficits

12/11/24, 12:00 AM

Many Patients With Schizophrenia Benefit From Guided Antipsychotic Tapering Program

10/22/24, 12:00 AM

Living Situation of People With ID Does Not Appear to Influence Antipsychotic Prescribing Decisions

10/11/24, 12:00 AM

FDA Approves Cobenfy, Antipsychotic With a New Approach to Schizophrenia

9/27/24, 12:00 AM

Researchers Propose Olanzapine and Perphenazine as First-Line Schizophrenia Treatments

9/6/24, 12:00 AM

Quetiapine, Clozapine, and Olanzapine Associated With Increased Pneumonia Risk

6/28/24, 12:00 AM

Risks of Clozapine Decline Sharply After Six Months, May Warrant Reduced Monitoring

4/30/24, 12:00 AM

Mirtazapine and Vitamin B6 May Be Best Options for Antipsychotic-Induced Akathisia

3/8/24, 12:00 AM

APA’s Good Faith Estimates Survey: Please Respond Today The No Surprises Act requires clinicians to ...